knowledge -WSS

knowledge

author：fashion 2025-09-29 13:30:39 - browse：5113

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields.

There were, of course, many contenders to choose from. For this second annual list, we’ve selected just 46 — an homage to the number of chromosomes in human DNA. Many are well-known as changemakers; others are largely unheralded heroes. They are CEOs, philanthropists, government officials, and health advocates. All have compelling stories to tell.

Our editorial team painstakingly researched and identified hundreds of finalists. In winnowing down the list, judges placed special emphasis on people who have sought to help others and build community in these often-divisive times. One note: Our news coverage is independent of this list, and we remain committed to tough-minded reporting on the people and institutions shaping life sciences.

While I have your attention, I want to point you to some of our most talked-about exclusive stories in recent days: A new STAT investigation exposes how Medicare Advantage plans use algorithms to cut off care for seniors in need, and we took a closer look at how a Medicare Advantage business is strangling one of its first funders. We’re aggressively reporting on the consequences for biotech of the Silicon Valley Bank collapse.

And over the coming months, in our series “The Obesity Revolution,” we’ll explore a class of obesity drugs that is transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years.

For full access to our exclusive reporting, please consider purchasing a STAT+ subscription. Get 15% off an annual subscription by using promo code STAT15 when you check out.

As always, please reach out to me with feedback. I’m at [email protected].

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： In early work, researchers turn to CRISPR to treat Alzheimer's

WSS

A Q&A with the global head of Boehringer Ingelheim's innovation unit

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

How Medicaid coverage policies for immigrants impact new moms

The future of health care in the House

In early work, researchers turn to CRISPR to treat Alzheimer's

Liquid biopsy for lung cancer is launched by Delfi

hotspot

knowledge

focus

Peter Hotez and the public health issue of online harassment

AI can’t replace a physician’s gut feeling

Sports medicine is finally prioritizing gender equality

Sanders adds drug shortage policies to pandemic preparedness bill

Guidelines to prevent youth baseball injuries need more muscle

Why hospitals are withdrawing from US News rankings

The high cost of giving birth even with insurance

Bill would stop addiction treatment from triggering child abuse inquiry

Drug repurposing or repositioning? The language matters

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

entertainment

Analysis of telehealth claims data suggest service duplication

Why Charlie Gard's case is so disturbing to Americans

Colorectal cancer study finds potential in overlooked immune cell

Senate panel eyes new effort on drug shortages

Why age limits for politicians are a terrible idea

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Wikipedia

hotspot

hotspot

focus